Boardroom Media (CEO News)
At CEO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top China based CEO’ operating in the Medical space. If you think a CEO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Steve Yang
Co-CEO of WuXi AppTec
Formerly Vice President and Head of Asia and Emerging Markets iMed at AstraZeneca; Vice President, Head of R&D Asia at Pfizer. Ph.D. in Pharmaceutical Chemistry from University of California, San Francisco.
Follow Steve Yang:
About WuXi AppTec: WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.
Ge Li
Founder, Chairman and CEO of WuXi AppTec
Ge Li (李革) is the founder of WuXi AppTec, a Chinese company that provides compliant discovery, testing, and contract manufacturing services for pharmaceutical and medical device companies. The company was founded in 2000. Li holds a bachelor’s degree in chemistry from Peking University and a doctorate in organic chemistry from Columbia University.
Follow Ge Li:
About WuXi AppTec: WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.
Edward Hu
Co-CEO of WuXi AppTec
Formerly Senior Vice President and Chief Operating Officer at Tanox, responsible for operations, finance, IT, project management and strategic planning. MBA and M.S. in Chemistry from Carnegie Mellon University.
Follow Edward Hu:
About WuXi AppTec, WuXi Healthcare Ventures: WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.
John V. Oyler
CEO & Founder of BeiGene
John V. Oyler is our Chairman and Co-Founder, and has served as our Chief Executive Officer and a member of our Board of Directors since 2010. From 2005 to 2009, Mr. Oyler served as President and Chief Executive Officer of BioDuro, LLC, a drug discovery outsourcing company, which was acquired by Pharmaceutical Product Development Inc. in 2010. From 2002 to 2004, Mr. Oyler served as Chief Executive Officer of Galenea Corp., a biopharmaceutical company dedicated to the discovery of novel therapies for central nervous system diseases, which initially were developed at Massachusetts Institute of Technology. From 1997 to 2002, Mr. Oyler was a Founder and the President of Telephia, Inc. which was sold to The Nielsen Company in 2007. From 1997 to 1998, Mr. Oyler served as Co-Chief Executive Officer of Genta Incorporated (NASDAQ: GNTA), an oncology‑focused biopharmaceutical company. Mr. Oyler began his career as a management consultant at McKinsey & Company. Mr. Oyler received his B.S. from Massachusetts Institute of Technology and MBA from Stanford University.
Follow John V. Oyler:
About BeiGene: BeiGene is a life sciences, biotechnology company.
Xuefeng Yu
Co-Founder, Chairma, and CEO of CanSinoBIO
Dr. Yu received his Ph.D. in Microbiology from McGill University, Canada and has been appointed as Adjunct Professor of Pharmacology at Nankai University, Tianjin. Over the past few years, he has been awarded the title of “Leading Entrepreneur in innovation” by Ministry of Science and Technology, China, “Leading Entrepreneur of Beijing-Tianjin-Hebei BioPharmaceutical Industrial Demonstration Area”. He was also elected as one of the Tianjin “1000-Talents” and a Distinguished Expert. He has over 25 years of experience in the biopharmaceutical industry. Previously, he served as Director, Bioprocess R&D, and Corporate Platform Leader at Sanofi Pasteur Inc., one of the world’s largest vaccine suppliers. In that role, he led vaccine upstream process R&D in Canada and coordinated global activities across three R&D sites. He also played key roles in GMP production, new GMP facility validation, technology transfer and regulatory submission. Before joining Sanofi, he was a scientist at IBEX Technologies Inc., Canada, focusing on therapeutic enzyme products development.
Follow Xuefeng Yu:
About CanSinoBIO: Tianjin CanSino Biotechnology Inc. is a vaccine manufacturing facility.
Wang Tao
Founder, Chairman, and CEO of Ping An Good Doctor
Mr. Wang Tao, in 2004 joined the Alibaba Group, as Vice President Group Technology, founded Alibaba B2B, Taobao and Alipay technology and operations platform to build in 2007, was promoted to senior vice president of Alibaba Group and Ali Software CEO, successfully created China’s largest online software applications operate an open platform, “the father of Chinese software operational applications of” known, is an early “Fab Five,” one of Ma. Kingsoft previously served as CTO, and Lei Jun partners launched the first large-scale online game “JX online”, help Kingsoft was listed. His 16-year-old was admitted to Nanjing University computer science junior class, 20-year-old master’s Computer America, is a true prodigy. Master after graduation to join Microsoft headquarters in the United States to any development manager involved in the development of Microsoft windows media, Office and other products. 2013 was invited to join Ma Mingzhe, chairman of Ping An Group, he served as chairman and CEO of Ping An Health. Meanwhile, the Internet elite led the team to create a safe and healthy Internet Co., Ltd., and served as chairman and CEO, the use of a year to build a successful Chinese mobile medical largest APP – Ping good doctor. May 2016, Ping An good doctor officially announced the completion of $ 500 million A round of financing, the valuation of $ 3 billion. The financing and refresh the worldwide mobile medical start-ups and the single largest financing round A record two highest valuation. Wang Tao, with just two years, the good doctor has put peace into a mobile medical field the largest domestic company Unicorn. As of June 2016, Ping good doctor more than 80 million registered users, daily advisory capacity 250,000 times, ranking China Top50 most active App.
Follow Wang Tao:
About Ping An Good Doctor: Ping An Good Doctor is an Online-to-offline (O2O) healthcare servicing platform.
Liao Jieyuan
Founder & CEO of WeDoctor
EMBA, Guanghua School of Management, Peking University. A founder of China’s intelligent speech recognition industry, owns many patents. Was director of 863 Program (National High-tech R&D Program); prior to Guahao, Liao founded enterprise communications company China Gtel, once worth RMB 300 million.
Follow Liao Jieyuan:
About WeDoctor: WeDoctor is the world’s leading medical health technology platform.
Jinzi Wu
Founder & President , CEO of Ascletis
Jinzi Wu is the Founder ,President & CEO at Ascletis.
Follow Jinzi Wu:
About Ascletis, Gannex: Ascletis is a specialty therapeutics company developing therapeutics for the treatment of cancer and infectious diseases.
Zi Zhenjun
Founder & CEO of Venus MedTech
Zi Zhenjun Hangzhou Qiming Medical Devices Co., Ltd. founder, but also the founder and management partner of Reno Capital. Was co-founder and director of Xianjian Technology (01302, HK). He was also the first R & D manager for minimally invasive medical (00853, HK), as well as the deputy general manager and R & D manager of Veken Medical Devices. As China’s first generation of coronary artery PTCA balloon, coronary stent, aortic aneurysm stent graft, left ear ear occluder of the main designers, developed China’s first generation of congenital heart disease interventional occluder and lower chamber Venous thrombosis filter products, and the successful introduction of products to the international market, with more than 30 domestic and foreign patents, presided over and participated in the national and local governments at all levels a total of 25 research projects.
Follow Zi Zhenjun:
About Venus MedTech: Venus MedTech is an national high-tech industrial development zone.
Zonghai Li
Founder, Chairman of the Board, CEO & CSO of CARsgen Therapeutics
Zonghai Li, M.D., Ph.D., is the Chairman, Chief Executive Officer, Chief Scientific Officer and Founder of CARsgen Therapeutics. He was a professor and now an adjunct professor in Shanghai Cancer Institute, Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine. Zonghai Li is dedicated himself to develop innovative treatment for the patients with cancer. One of his early career achievements is the identification of GE11, a peptide ligand of EGFR which has become the most widely used unnatural peptide in antitumor study now. He is the inventor of many new technologies such as Hpd3cell, a new phage display technology; FR806, a new safety switch for T cell therapy; Run-CAR technology to increase the antitumor activities of chimeric antigen receptor (CAR) T cells. He has a leading role in the research on CAR T cell therapy against solid tumors by publishing the first paper of CAR T cell therapy against GPC3, Claudin18.2 and EGFR/EGFRvIII worldwide. Zonghai Li earned a M.D. and M.S. from Xiangya Medical School of Central South University and a Ph.D. from Shanghai Medical College of Fudan University.
Follow Zonghai Li:
About CARsgen Therapeutics: CARsgen is a leading immunotherapy company focused on the development of new chimeric antigen receptor
Wei William Cao
Founder, Chairman and CEO of Gracell Biotechnologies
Follow Wei William Cao:
About Gracell Biotechnologies: Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Ye Yin
CEO of BGI Group
Ye Yin is CEO of BGI Genomics Co., Ltd. He joined BGI in 2002 and played an indispensable role in fighting against SARS, which has become his first achievement in the early career. He has been in charge of all the scientific collaboration business worldwide, from sales activities to market management, and to technical support in BGI. With BGI’s rapid development into the world-leading organization in genomic field and into diagnostics and agriculture industry, he contributed in the acquisition of Complete Genomics in 2013 and the smooth merge of CG with BGI. Ye has abundant experiences on massive lab production and quality management. He has successfully guided several international projects, like “1000 Plant and Animal Reference Genomes project”, “One Million Human Genomes re-sequencing project” and so on. He has several publications of genome research projects and genetic insights into medical research.
Follow Ye Yin:
About BGI Group: BGI Group is one of the world’s largest DNA sequencing service providers.
Raymond Stevens
Chief Executive Officer & Founder of ShouTi
Raymond Stevens is the Chief Executive Officer at ShouTi.
Follow Raymond Stevens:
About ShouTi: ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR.
Hong Tan
Founder and Chief Executive Officer of ET Healthcare
Hong Tan, PhD, Founder and Chief Executive Officer, began his entrepreneurial career in 2000 when he founded Wave Crossing, a fiber optics company that developed a self-focus lens technology widely used in the optic fiber networks. In 2001, Hong founded FortéBio, where he led the creation of the Bio-layer Interferometry technology. Before starting his entrepreneurial endeavor, he worked for several data storage companies, including Iomega, Seagate, and Maxtor. Hong was responsible for the control system for the High Energy Imaging Device, a NASA space telescope project. He received Ph.D. and MSEE from Auburn University, BSEE from Xi’an Jiao Tong University, and EMBA from Cheung Kong Graduate School of Business.
Follow Hong Tan:
About ET Healthcare: ET Healthcare is an in vitro diagnostic technology company.
Chen Kuan
Founder and CEO of Infervision
Chen Kuan is founder and CEO at Infervision. He is a graduate of the University of Chicago, where he studied under four Nobel Prize winners, Gary Becker, Robert Fogel, James Heckmanm, and Lars Hansen. Chen also studied financial modeling and intelligent modeling in the Double Doctor Degrees Program of Economics and Finance. He founded the company in 2015.
Follow Chen Kuan:
About Infervision: Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Scott Liu
Co-Founder & CEO of Shanghai Henlius Biotech
Dr. Scott Liu, one of the global partners of Fosun International Limited, the Co-founder, President and CEO at Shanghai Henlius Biotech Inc., a global biopharmaceutical company focusing on the development, production and commercialization of high-quality and affordable biosimilar, biobetter and novel therapeutic monoclonal antibodies. Under his leadership, Henlius has become a leader of therapeutic monoclonal antibodies to treat a range of chronic and life-threatening diseases in China.Dr. Liu has more than 25 years of experience in biopharmaceutical R&D, manufacturing and quality management. Prior to joining Fosun Group in 2010, he has previously served several executive positions such as Vice President of R&D at United Biomedical, the Founding Director of the Biologics QC Department at Bristol-Myers Squibb (Syracuse, USA), and the Director of QAL (QC) at Amgen (Fremont, USA). Because of his extensive knowledge in quality and control of biologics, Dr. Liu had provided assistance to the CDE of CFDA in developing and implementing quality standards for biosimilars and novel biologics in China. Furthermore, Dr. Liu led the promotion of industry-wide adoption of single-use manufacturing technology to support the production of clinical and commercial monoclonal antibody therapeutics, and actively participated in the development of Technical Guidelines of Biosimilar Development and Evaluation to promote the innovation and globalization of the biopharmaceutical industry in China.Dr. Liu was the recipient of the the Bristol-Myers Squibb“Technical Operations Presidential Award”in 2004 and was recognized in 2013 as an expert of the “Thousand Talents Plan of Shanghai”. Dr. Liu received his Ph.D. degree in Biology from the Purdue University with postdoctoral training in Biology at Stanford University and studied business administration (iMBA courses) at the Syracuse University.
Follow Scott Liu:
About Shanghai Henlius Biotech: Shanghai Henlius Biotech is joint venture company that provides clinical-stage biopharmaceutical services.
Shiang Huang
Founder, CEO of Kindstar Global (Beijing) Medicine Technology
Shiang Huang (黄士昂) is the founder and chief executive officer of Kindstar Global (Beijing) Medicine Technology, a company providing advanced and specialized inspection services for hospitals. Huang is a director of Union Hospital affiliated with the TongJi Medical College of Huazhong University of Science and Technology and the Center for Stem Cell Research and Application. He is also a deputy director of the Institute of Hematology and director of the Hubei Key Laboratory of Biological Target Therapy.
Follow Shiang Huang:
About Kindstar Global (Beijing) Medicine Technology: Kindstar Global Medicine Technology is a Chinese high-tech enterprise that provides specialized inspection services for hospitals.
Frank Jiang
CEO of CStone Pharmaceuticals
Frank Jiang, MD, PhD joined CStone Pharmaceuticals in July, 2016 as its CEO. CStone Pharmaceuticals is a Chinese biotech company focused on addressing the most important patient needs in China and beyond. With immuno-oncology as CStone’s core therapeutic focus, the company strives to lead Chinese research to the global market through its world class R&D team, its innovative portfolio, and an open innovation strategy.
Follow Frank Jiang:
About CStone Pharmaceuticals, Sanofi China: CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Zheng Wei
Co-founder, CEO of Connect Biopharmaceuticals
Zheng Wei has been serving as our CEO since he co-founded the company in 2012. He has over 25 years of biopharmaceutical industry experience in the autoimmune diseases and inflammation therapeutic areas. Prior to co-founding Connect, Dr. Zheng was Director of Immunology at Arena Pharmaceuticals where he oversaw its immunology discovery programs. Prior to serving at Arena, Dr. Zheng was a founding scientist at ChemoCentryx. During his 10-year tenure at ChemoCentryx, he led the implementation of the company’s proprietary technology platform, and the discovery of drug candidates that entered Phase II and Phase III clinical trials for autoimmune disease indications including Crohn’s disease. His discovery research contributed significantly to the landmark strategic alliance between the company and GSK. Prior to joining ChemoCentryx, Dr. Zheng was a scientist at Glycomed (acquired by Ligand Pharmaceuticals). He also conducted immunology research at Stanford University School of Medicine. Dr. Zheng is an inventor of 16 issued patents and several pending patent applications on immunology related therapeutic agents and technologies. He received his Ph.D. in Biochemistry and Molecular Biology from the University of California at Davis. He has been selected to the National 1000Talents Plan of China.
Follow Zheng Wei:
About Connect Biopharmaceuticals, Northern Light Venture Capital: Connect Biopharma is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Ed Deng
Representative Director, CEO, and Founder of Health2Sync
Ed Deng is the Representative Director, CEO and Founder at Health2Sync.
Follow Ed Deng:
About Health2Sync: Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
Yusheng Han
CEO & Founder of Burning Rock Biotech
Yusheng Han is a Founder of Burning Rock, established Burning Rock in 2014, engaged in investment of medical fields; with successful experience in establishing and operating a start-up team; with six years of working experience in the field of life science.
Follow Yusheng Han:
About Burning Rock Biotech: Burning Rock Biotech focuses on providing individualized cancer treatment guidance for the patients.
Yan Tan
Co-Founder & Chief Executive Officer of Xbiome
Yan Tan is the Co-Founder & Chief Executive Officer at Xbiome.
Follow Yan Tan:
About Xbiome: Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.
Tao He
Founder & CEO of Miaoshou Doctor
Follow Tao He:
About Miaoshou Doctor: Miaoshou Doctor is a health care platform that provides communication services between doctors and patients.
Shirui Wang
Founder and CEO of Medlinker
Graduated from the West China School of Stomatology, Sichuan University, with an eight-year undergraduate, master’s and doctoral degree, and a research scholar at Harvard University. In 2014, Wang Shirui established the Medical Federation. In 2016 and 2018, he was twice selected as the “40 Business Elites under 40 in China” by the Chinese version of Fortune. In 2017 and 2018, he was selected as the “Top Ten New Economic Leaders of Sichuan” twice. In addition, Wang Shirui was also selected as the “Innovative Talent” announced by the Ministry of Science and Technology, and the National “Ten Thousand-Year Plan” Technology Innovation Leading Talent issued by the Organization Department of the CPC Central Committee.
Follow Shirui Wang:
About Medlinker: Medical Alliance is a post of physician social service platform.
Cheney Mao
Founder, Chairman, Chief Executive Officer, and Executive Director of Viva Biotech
Chen (Cheney) Mao is the Chairman, Chief Executive Officer, and an Executive Director of our Company. He is primarily responsible for the overall strategic planning and business development of the Group. Chen Mao has over 20 years of experience in the CRO industry. Chen Mao obtained his bachelor’s and master’s degree from Fudan University in the PRC, and obtained his Ph.D. degree in biochemistry from Cornell University in the U.S. After graduation, he served as a director of the Department of Structural Biology of Parker Hughes Institute. He also served as a reviewer on the U.S. National Institutes of Health Review Panel ZRG1 AARR-1(50) in relation to AIDS-related structural biology projects grants.
Follow Cheney Mao:
About Viva BioInnovator, Viva Biotech: Viva Biotech is a Healthcare Start Up Based In Shanghai.
Steve Tan
CEO, Healthcare Software BU of United Imaging Healthcare
Follow Steve Tan:
About United Imaging Healthcare: United Imaging Healthcare develops and manufactures medical equipment and solutions.
Oscar Y. Wu
Managing Director/CEO of Ondal Medical Systems
Oscar Y. Wu is the managing director/CEO at Ondal Medical Systems Asia Pacific. He is responsible for overseeing operations for the China and Asia-Pacific region.
Follow Oscar Y. Wu:
About Ondal Medical Systems: Ondal Medical Systems designs, develops, and manufactures electromechanical equipment for use in operating rooms and intensive care units.
Du Bo
Co-Founder and CEO of GeneCast Biotechnology
Du Bo, Co-founder and CEO of Genecast (Beijing) Biotechnology Co., also a member of the Biotech Diagnosis Branch of China Medicinal Biotech Association. As one of the earliest developers to enter the field of NGS in China, Du Bo also co-founded China’s first NGS reagent manufacturer, Quest Genomics (Nanjing) Co., Ltd. Du Bo has accumulated rich experience in investment, pharmaceuticals, and second-generation sequencing, which renders him deep insights in corporate strategic development and management. He has frequently been invited to deliver speeches at conferences in biomedical field, and has won numerous awards, including the prestigious China Pharmaceutical Association’s Technology Progress Award. Du Bo graduated from the department of biology of Peking University.
Follow Du Bo:
About GeneCast Biotechnology: GeneCast Biotechnology is dedicated to improving cancer treatment through precision cancer diagnostics and companion diagnostics.
Feng Wang
Co-Founder & Co-CEO of Imsight
Within his 18 years career with Lenovo Group, he was appointed as Vice President and also served as general manager of Lenovo Mobile marketing and sales, general manager of CSMB Business in China, general manager of Lenovo Regional management. During his appointment with Lenovo, he guided the Lenovo CSMB business ahead of other competitors maintaining the first position of China’s Market Share, while repeatedly achieved historical high rankings.
Follow Feng Wang:
About Imsight: Imsight Medical develops artificial intelligence assisted medical imaging analysis tools.
Daixing Zhou
CEO of Berry Genomics
Dr. Daixing Zhou is the Chief Executive Officer of Berry Genomics Co., Ltd, located in Beijing, China. Prior to founding Berry Genomics, Dr. Zhou held multiple positions in the next generation sequencing industry, including the Leader of Market Development at Life Technologies Corp., the Head of Sequencing Sales at Illumina-Asia Pacific Japan, and the Director of Bioinformatics at Solexa Inc/Lynx Therapeutics. Dr. Zhou earned his Ph.D. from University of Maryland at Baltimore, and completed his postdoctoral training at Duke University.
Follow Daixing Zhou:
About Berry Genomics: Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.
Xueming Qian
Founder, Chairman and Chief Executive Officer of MabSpace Biosciences
XuemingQian has over eighteen years of industrial antibody discovery and development experience. Before starting MABSPACE, XuemingQian was Senior VP and Head of R&D of Shenogen Pharma Group from 2010 and 2012; a Beijing-based biopharma company developing ER-a36 based anti-cancer therapies. From 1997 and 2010 XuemingQian worked at Amgen as principal scientist and led multiple project teams to discover novel antibody therapeutics for the autoimmune diseases and metabolic disorders (bone and kidney). He is the leading inventor of multiple antibody patents.XuemingQian graduated from Fudan University and completed his graduate studies at Columbia University and Albany Medical Center. He is a member of Antibody Society, International Society of Nephrology and BayHelix，a member of National Thousand Talents program.
Follow Xueming Qian:
About MabSpace Biosciences, Transcenta: MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Jin Li
Founder, Chairman & CEO of HitGen
Dr. Li Jin has worked in the world’s top 500 companies, as the global compound science/computing science director of AstraZeneca, one of the world’s four largest pharmaceutical giants, and has more than 30 years of experience in drug development and scientific research management. Mainly responsible for computational science, computational chemistry, computational biology, and compound screening optimization. Dr. Li Jin graduated from the Department of Chemistry of Sichuan University and obtained a Ph.D. in polymer science from Aston University in the United Kingdom. He then engaged in postdoctoral research in biochemistry at the University of Manchester.
Follow Jin Li:
About HitGen: HitGen is provides biological reagents and services to support drug discovery research.
Ma Xuguang
Co-Founder and CEO of Medbanks
Ma Xuguang is the co-founder and CEO of Medbanks.
Follow Ma Xuguang:
About Medbanks: Medbanks is a database platform of clinical and professional medical services for clinical oncology.
Yeqing Zhu
CEO of New Horizon Health
Follow Yeqing Zhu:
About New Horizon Health: New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.
He Ting
CEO of Immunochina
He Ting graduated from the Department of Biology in Tsinghua University with a Ph.D. degree, with his research interest in cancer immunology and metastasis during his graduate study. In 2015, Ting established ImmunoChina Pharmaceuticals Co. Ltd. and has worked as the CEO since then. ImmunoChina has received several rounds of investment by venture capitals such as Peter Thiel and Legend Capital, and now it is the leading bio-company focusing on innovative CAR-T therapy in China.
Follow He Ting:
About Immunochina: Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.
Menge Cheng
Co-CEO of Mindray Medical International
Menge Cheng is Co-CEO at Mindray Medical International.
Follow Menge Cheng:
About Mindray Medical International: Mindray Medical International Limited is China’s largest medical equipment manufacturer, developing, manufacturing, and marketing.
Weiqi Liu
CEO of UNIMED
Follow Weiqi Liu:
About UNIMED: UNIMED provides integrated medical service models.
Xiaodong Wu
CEO of China Medical Technologies
Follow Xiaodong Wu:
About China Medical Technologies: China Medical Technologies is a medical device company that develops, manufactures products using HIFU for the treatment of solid cancers.
Bob Liu-Bellenchem
Co-founder & CEO of Bellen
Follow Bob Liu-Bellenchem:
About Bellen: A Chinese medical contract research organization.
Paul Wang
CEO & Founder of LyncMed
Follow Paul Wang:
About LyncMed: Business-to-business medical device trading platform based in Beijing.
Jin Xing
CEO of SoYoung Technology
Follow Jin Xing:
About SoYoung Technology: SoYoung Technology is a provider of digital services and technology advances.
Kimsung Jin
Founder and CEO of SoYoung Technology
Kimsung Jin is a Founder & CEO at Beijing Soyoung Technology Co., Ltd, The Standing president of China Medical Treatment Orthopedics and Beauty Association Internet branch.From the friends around the plastic failure experience, he realize that plastic beauty industry has been rapidly developed in our country, but the scale of the hospital and technique level of operate varies greatly. In this way, Soyoung was born.
Follow Kimsung Jin:
About SoYoung Technology: SoYoung Technology is a provider of digital services and technology advances.
James Foster
Chief Executive Officer and Founder of Virax Biolabs
James Foster is the Chief Executive Officer and Founder of Virax Biolabs.
Follow James Foster:
About Virax Biolabs: Virax Biolabs is an innovative Biotechnology company focused on the prevention, detection and diagnosis of viral diseases
Jie Qin
Co-Founder, CEO & Chairman of Forerunner Medical
Mr. Jie Qin is Chairman at Shanghai Kinetic Medical Co., Ltd. He is on the Board of Directors at Essen Technology (Beijing) Co., Ltd., Foreruner Venture Ltd., Ultra Tempo Ltd. and MedSphere International (Shanghai) Co., Ltd. Mr. Qin was previously employed as Co-Founder by Forerunner Medical Equipment Technology Shanghai Co. Ltd.
Follow Jie Qin:
About Forerunner Medical: Forerunner Medical is a manufacturer of innovative medical devices for minimally invasive treatment.
Min Lu
Founder and CEO of Nuanwa Technology
Lú Mín is the founder and CEO of Nuanwa Technology.
Follow Min Lu:
About Nuanwa Technology: Nuanwa Technology is a tech-driven medical insurance service company.
Robert Braithwaite
Co-Founder & CEO of Luqa Pharmaceuticals
Robert Braithwaite is the Co-Founder & CEO at Luqa Pharmaceuticals
Follow Robert Braithwaite:
About Luqa Pharmaceuticals: Luqa Pharmaceuticals is a China-focused company.
Jin Zhang
CEO and Founder of DXY
Jin Zhang is the Chief Executive Office and product director of DXY, a media platform focused on the areas of pharmaceuticals and life sciences. He joined DXY in 2008. Zhang began medical practice on the internet in 1999 and has a thorough understanding of web-based design in medical and health fields. He also worked at the first affiliated hospital of the College of Medicine of Zhejiang University. Zhang obtained his degree in medicine from Hsiang-Ya Medical College of Central South University in 2004.
Follow Jin Zhang:
About DXY: DXY is an online healthcare community for doctors, consumers, and healthcare organizations.
Libo Yang
CEO of Kanghui
Yang Libo is the CEO of Kang Hui Medical Instrument.
Follow Libo Yang:
About Kanghui: Kanghui is a professional medical instrument enterprise focused on the R&D and production of orthopedic devices.
Junling Liu
Co-Founder, Chairman and Chief Executive Officer of 111, Inc.
Junling Liu is the co-founder, Chairman and CEO of 111,Inc., a leading digital and mobile health group in China since 2015. Before 111,Inc., Junling Liu was the Co-Founder of online retailer Yihaodian, one of the most successful online retailers in China. Yihaodian was founded in 2008 and is now China’s largest on-line retailer. In November 2011, Deloitte recognized Yihaodian as the fastest growing company in the Asia Pacific Region. Yihaodian has since received capital investment from global retailing company Walmart. Before co-founding Yihaodian, Junling Liu was Co-President of Dell China and Hong Kong, and also held senior management positions with Avaya China, Avaya Asia Pacific and Lucent Technologies. Junling Liu has been named a Top 10 Financial Figure of the Year in China’s IT Industry in 2006, and a Top 10 Figure of the Year in the Computer World in 2007.
Follow Junling Liu:
About 111, Inc.: 111, Inc. operates as a digital and mobile healthcare platform.
Liang Liang
CEO & Co-founder of Easyhin Technology
Liang Liang is the Co-founder & CEO at Easyhin Technology.
Follow Liang Liang:
About Easyhin Technology: Easyhin Technology is an mobile internet company on healthcare management of women and children.
JingJia Liu
Co-founder & CEO of Wision A.I.
Follow JingJia Liu:
About Wision A.I.: Build Computer Aided Diagnosis (CAD) algorithms and systems in clinical imaging, to improve diagnostic accuracy and effectiveness.
Kent Zaitlik
Founder & CEO of MOZI
Follow Kent Zaitlik:
About MOZI: MOZI builts a suite of AI tools for scientists to use on their discovery of next generation therapeutics.
Ping Chen
CEO & Founder of Lianluo Smart Ltd.
Ping Chen is a Chief Executive Officer, Director of Lianluo Smart Limited (formely known Dehaier Medical Systems Limited). He was Chairman of the Board, Chief Executive Officer of Dehaier Medical Systems Ltd.
Follow Ping Chen:
About Lianluo Smart Ltd.: Lianluo Smart Ltd. engages in the development, manufacturing, marketing and distribution of medical products.
Yang Ling
President and Chief Executive Officer of Beijing Gene+ Technology
Doctor of Medicine, Associate Researcher, Master’s Tutor of Chinese Academy of Sciences, Member of Professional Committee of Health Risk Assessment and Control of Chinese Preventive Medicine Institute, engaged in R & D and clinical examination of gene health field for more than ten years, served as Head of Health Department of Huada, Shenzhen Huada Director of clinical examination center, general manager of Tianjin Huada, director of Shenzhen Municipal Key Laboratory of pathogen nucleic acid detection, director of Shenzhen Key Laboratory of Clinical Molecular Diagnosis, director of Tianjin Medical Genomics Engineering Center and director of Tianjin Key Laboratory of Enterprise , Has a wealth of clinical testing and company operating experience.
Follow Yang Ling:
About Beijing Gene+ Technology: Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention
Ligang Zhang
Founder, Chairman and CEO of iKang Healthcare Group
Zhang Ligang is the founder, Chairman and CEO of iKang Health Group, a provider of private preventive healthcare services in China. Ligang acquired ShanghaiMed Company Limited in 2003 and serves as of Chairman and CEO of the company. His past employers include Sohu, Elong and Shanghai Med Company Limited. Ligang attended Fudan University, Columbia University and Harvard University. He served as President and publisher of Harvard China Review.
Follow Ligang Zhang:
About iKang Healthcare Group: Ikang is a Chinese health management service agency providing personalized health-related services.
Xiangfei Chai
Founder & CEO of Huiyi Huiying
Obtained Postdoctoral fellow in Stanford University, doctor degree in medical physics major in Amsterdam University in Holland. He had studied and worked in the world top medical imaging organizations, such as cancer center of Stanford University, Holland cancer research center and radiology department in Leuven University. He has over 10 years experience on interdisciplinary scientific research and project in the field of Artificial Intelligence, image processing, and data analysis, with the good knowledge of the core technology of image segmentation, identification, analysis and deep learning algorithm. He has been honored “Top 30 AI Start-up entrepreneur” and “Best Youth Model”. Xiangfei Chai also was the the first term trainee of Qingteng University held by Tencent.
Follow Xiangfei Chai:
About Huiyi Huiying: Huiyi Huiying is an international cloud computing & AI tech that has created a digital medical imaging and tumor radiotherapy platform.
Philip Li Wang
Founder and CEO of Bioheart
Philip Li Wang is the Founder and CEO at Bioheart.
Follow Philip Li Wang:
About Bioheart: Bioheart is develop high-value minimally invasive therapeutic products, provide better medical products and technologies.
Ying Zhong
Executive Director and Chief Executive Officer of Jinxin Fertility
Follow Ying Zhong:
About Jinxin Fertility: Jinxin Fertility is a Chinese fertility services provider.
Gong Jianbo
CEO of Shandong Weigao Orthopedic Device Company
Gong Jianbo aged 47, was appointed as our Director on April 6, 2005 and redesignated as our executive Director on October 22, 2014. He is also the chief executive officer. Mr. Gong has over 20 years of experience in orthopedic implant industry in China. Mr. Gong joined our Group on April 6, 2005. He has been an executive director of Weigao Medical Polymer since March 2013 and the general manager of our Group since March 2005.
Follow Gong Jianbo:
About Shandong Weigao Orthopedic Device Company: Shandong Weigao Orthopedic Device Company is a medical device company in China specializing in the research and development, production.
Bing Wu
Founder, CEO of ChronoCloud
Follow Bing Wu:
About ChronoCloud: ChronoCloud is committed to people’s daily health management and disease prevention and control.
Shihe Wang
Founder & CEO of Rimag
Wang Shihe has been in the medical industry for nearly 20 years. He is the founder of Tianyue Group and the founder of Beijing Hezhong Yifang. Formerly a doctor in a public tertiary hospital, he left the hospital in 2002 to establish the Tianyue Group, which is mainly engaged in the sales and services of medical equipment, and is currently a large domestic partner for medical equipment such as GE. In 2010, with the development of the mobile Internet, he entered the fields of “medical informatization” and “mobile medical”, and founded Jiangxi Zhongtongbit Medical Information Co., Ltd. He has a profound medical industry from a “doctor” to an “entrepreneur”. Resources and industry understanding.
Follow Shihe Wang:
About Rimag: Rimag is a Shenzhen-based medical imaging service provider.
Jiang Lei
Founder and CEO of Ennovabio
Jiang Lei is a Co-Founder and CEO at EnnovaBio.
Follow Jiang Lei:
About Ennovabio: Ennovabio is a Chinese drug developer that focuses on creating drugs targeting brain glioma.
Qiu Yufeng
Founder & CEO of Zorpia Robot
Qiu Yufeng is the founder and CEO of Zorpia Robot.
Follow Qiu Yufeng:
About Zorpia Robot: Zorpia Robot offers opportunities for the disabled to perform daily activities by themselves.
Qiu Yufeng
Founder & CEO of Zorpia Robot
Qiu Yufeng is the founder and CEO of Zorpia Robot.
Follow Qiu Yufeng:
About Zorpia Robot: Zorpia Robot offers opportunities for the disabled to perform daily activities by themselves.
Dong Lin
Founder and CEO of Sirui Jiankang
Dong Lin is the founder of Sirui Jiankang, a healthcare company based in Shenzhen.
Follow Dong Lin:
About Sirui Jiankang: Sirui Jiankang develops a connected smart device for online medical consultation, electronic prescription, and basic healthcare checkups.
Dong Lin
Founder and CEO of Sirui Jiankang
Dong Lin is the founder of Sirui Jiankang, a healthcare company based in Shenzhen.
Follow Dong Lin:
About Sirui Jiankang: Sirui Jiankang develops a connected smart device for online medical consultation, electronic prescription, and basic healthcare checkups.
John Zhu
Founder and CEO of Duality Biologics
John Zhu is the Founder and CEO at Duality Biologics.
Follow John Zhu:
About Duality Biologics: Duality Biologics is a company focusing on the discovery, development and commercialization of new modality biologics to provide solutions.
Shen Yang
CEO & Cofounder of Kanchufang
Follow Shen Yang:
About Kanchufang: Sick how to do? People always have to run around looking for treatment options endless.
Gaoming Chen
Founder and CEO of Comma Bio
Gaoming Chen is the Founder and CEO of Comma Bio.
Follow Gaoming Chen:
About Comma Bio: Comma Bio is a manufacturer of molecular diagnostics and chromatographic mass sample pre-processing tools and laboratory consumables.
Zhimin Li
CEO of Annoroad
Follow Zhimin Li:
About Annoroad: Annoroad is leading developer and marketer on genomic innovation technologies for research and clinical market.
Zhimin Li
CEO of Annoroad
Follow Zhimin Li:
About Annoroad: Annoroad is leading developer and marketer on genomic innovation technologies for research and clinical market.
Minghua Lv
CEO of Shanghai eChinaChem, Inc.
Minghua Lv (吕明华) is the chief executive officer of Shanghai eChinaChem, a medical company that combines websites, magazines, conferences, and data information services for the chemical pharmaceutical industry. Prior to that, he served as a business manager for USA Amazon Network Company’s Silicon Valley department. Lv obtained a bachelor’s degree in chemistry engineering from Zhejiang University. He also holds a master’s degree from Yale University and an MBA from Kellogg School of Management of Northwestern University.
Follow Minghua Lv:
About Shanghai eChinaChem, Inc.: Shanghai eChinaChem is a pharmaceutical company that provides magazines, electronic newspapers, and buyers’ guides.
Minghua Lv
CEO of Shanghai eChinaChem, Inc.
Minghua Lv (吕明华) is the chief executive officer of Shanghai eChinaChem, a medical company that combines websites, magazines, conferences, and data information services for the chemical pharmaceutical industry. Prior to that, he served as a business manager for USA Amazon Network Company’s Silicon Valley department. Lv obtained a bachelor’s degree in chemistry engineering from Zhejiang University. He also holds a master’s degree from Yale University and an MBA from Kellogg School of Management of Northwestern University.
Follow Minghua Lv:
About Shanghai eChinaChem, Inc.: Shanghai eChinaChem is a pharmaceutical company that provides magazines, electronic newspapers, and buyers’ guides.
Xia Liu
CEO of Laoken Medical Technology
Xia Liu (刘霞) is the director of Chengdu Laoken Technology Co., Ltd., a high-tech company that is focused on the research and development of sterilization and disinfection products. Liu obtained her MBA from Peking University and master’s degree in private equity and entrepreneurship from Fudan University. After which, she went on to obtain her PhD in business administration from Southwestern University of Finance and Economics.
Follow Xia Liu:
About Laoken Medical Technology: Laoken Medical Technology is focused on the R&D and production of sterilization and disinfection products.
Qian Weijia
GM & CEO of DJ HealthUnion Systems Corp
Follow Qian Weijia:
About DJ HealthUnion Systems Corp: A provider of digital hospital solutions in China
Fangping He
Co-Founder, CEO of Zhuhai OmeSoft
Fangping He (何方平) is the CEO and a co-founder at Zhuhai OmeSoft, an application developer of mobile medical health. Prior to that, he served as the general manager of OmeSoft Technology Co., Ltd. Since August 2009. He also worked as ice president in the Sino-US joint venture Zhuhai Funiya Medical Equipment Co., Ltd. from 2005 to 2009. He studied at the Medical Department of Third Military Medical University from 1979-1984 and received his bachelor’s degree in 1984. He studied at the Department of Preventive Medicine of Military Medical Science Academy from 1987 to 1990 and received his master’s degree in 1990.
Follow Fangping He:
About Zhuhai OmeSoft: Zhuhai OmeSoft is a Chinese company engaged in the development of mobile medical health-related products.
Yu Yuan
Chief Executive Officer of Yuntai Network
Yu Yuan is Chief Executive Officer at Yuntai Network.
Follow Yu Yuan:
About Yuntai Network: Yuntai Network provides mobile Internet medical integrated service such as financial security and cloud hospital solutions.
Yi Pu
Founder, CEO of Baitianshi
Yi Pu (蒲易) is the founder and chief executive officer of Baitianshi.com, a social network that enables doctors and medical workers to share internal and external resources. He used to serve as a partner of DT Capital, participating in the investments in Dianping.com, Inventronics, Moonbasa, Gfan.com, and more. Pu obtained a bachelor’s degree in accounting from the University of Melbourne.
Follow Yi Pu:
About Baitianshi: Baitianshi.com is a social network for doctors and medical workers to discuss and share information, documents, and more.
